Portfolio company
MUVON Therapeutics AG
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This digital health company develops autologous muscle precursor cell therapies to treat stress urinary incontinence and skeletal muscle degradation in patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
MYOPOWERS MEDICAL TECHNOLOGIES SA
This company develops implantable artificial muscle technology to restore muscle function for patients suffering from conditions such as stress urinary incontinence.
Renalis
This company develops digital therapeutics to help patients manage pelvic health disorders such as overactive bladder.
Axena Health
This company develops a prescription medical device and app for women to treat urinary and faecal incontinence through at-home pelvic floor muscle training.
Vivira Health Lab
This company develops a digital therapeutic application providing personalised movement therapy for patients with musculoskeletal pain.
Minze
This company develops digital diagnostics and therapeutic platforms for urologists to treat patients with urinary tract symptoms and bladder conditions at home.
Kranus Health
This company develops prescription digital therapeutic applications for patients with urological conditions such as erectile dysfunction and enlarged prostates.
MyoPax
This company develops muscle regeneration cell and gene therapies for patients with congenital malformations, trauma, hereditary dystrophies and muscle wasting disorders.
Minze Health
This company develops digital urology diagnostics and therapeutic systems, including automated bladder diaries and uroflowmeters, for hospitals, urologists, and patients with voiding disorders.
